These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33683625)

  • 1. Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention.
    GhavamiNejad A; Lu B; Samarikhalaj M; Liu JF; Mirzaie S; Pereira S; Zhou L; Giacca A; Wu XY
    Drug Deliv Transl Res; 2022 Apr; 12(4):792-804. PubMed ID: 33683625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon.
    GhavamiNejad A; Li J; Lu B; Zhou L; Lam L; Giacca A; Wu XY
    Adv Mater; 2019 Jul; 31(30):e1901051. PubMed ID: 31165524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Smart" Composite Microneedle Patch Stabilizes Glucagon and Prevents Nocturnal Hypoglycemia: Experimental Studies and Molecular Dynamics Simulation.
    Lu B; GhavamiNejad A; Liu JF; Li J; Mirzaie S; Giacca A; Wu XY
    ACS Appl Mater Interfaces; 2022 May; 14(18):20576-20590. PubMed ID: 35471922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-demand transdermal insulin delivery system for type 1 diabetes therapy with no hypoglycemia risks.
    Fu Y; Liu P; Chen M; Jin T; Wu H; Hei M; Wang C; Xu Y; Qian X; Zhu W
    J Colloid Interface Sci; 2022 Jan; 605():582-591. PubMed ID: 34343731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual self-regulated delivery of insulin and glucagon by a hybrid patch.
    Wang Z; Wang J; Li H; Yu J; Chen G; Kahkoska AR; Wu V; Zeng Y; Wen D; Miedema JR; Buse JB; Gu Z
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29512-29517. PubMed ID: 33177238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin.
    Seong KY; Seo MS; Hwang DY; O'Cearbhaill ED; Sreenan S; Karp JM; Yang SY
    J Control Release; 2017 Nov; 265():48-56. PubMed ID: 28344013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Correction of the Hypoglycemia State in Nonhuman Primates Using a Glucagon Long-Dissolving Microneedle Patch.
    Yu X; Wen X; Xu J; Zhou Q; Chen Y; Qu F; He M; Chang H; Zheng C
    ACS Biomater Sci Eng; 2024 May; 10(5):3086-3096. PubMed ID: 38588325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZT-01: A novel somatostatin receptor 2 antagonist for restoring the glucagon response to hypoglycaemia in type 1 diabetes.
    Farhat R; Aiken J; D'Souza NC; Appadurai D; Hull G; Simonson E; Liggins RT; Riddell MC; Chan O
    Diabetes Obes Metab; 2022 May; 24(5):908-917. PubMed ID: 35060297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Smart" Matrix Microneedle Patch Made of Self-Crosslinkable and Multifunctional Polymers for Delivering Insulin On-Demand.
    Liu JF; GhavamiNejad A; Lu B; Mirzaie S; Samarikhalaj M; Giacca A; Wu XY
    Adv Sci (Weinh); 2023 Oct; 10(30):e2303665. PubMed ID: 37718654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery.
    Yu J; Zhang Y; Ye Y; DiSanto R; Sun W; Ranson D; Ligler FS; Buse JB; Gu Z
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8260-5. PubMed ID: 26100900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats.
    Karimian N; Qin T; Liang T; Osundiji M; Huang Y; Teich T; Riddell MC; Cattral MS; Coy DH; Vranic M; Gaisano HY
    Diabetes; 2013 Aug; 62(8):2968-77. PubMed ID: 23630299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes.
    Leclair E; Liggins RT; Peckett AJ; Teich T; Coy DH; Vranic M; Riddell MC
    Diabetologia; 2016 Aug; 59(8):1724-31. PubMed ID: 27075449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes.
    D'Souza NC; Aiken JA; Hoffman EG; Atherley SC; Champsi S; Aleali N; Shakeri D; El-Zahed M; Akbarian N; Nejad-Mansouri M; Bavani PZ; Liggins RL; Chan O; Riddell MC
    Front Pharmacol; 2024; 15():1302015. PubMed ID: 38510652
    [No Abstract]   [Full Text] [Related]  

  • 14. Touch-actuated microneedle array patch for closed-loop transdermal drug delivery.
    Yang J; Chen Z; Ye R; Li J; Lin Y; Gao J; Ren L; Liu B; Jiang L
    Drug Deliv; 2018 Nov; 25(1):1728-1739. PubMed ID: 30182757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-responsive microneedle patch for closed-loop dual-hormone delivery in mice and pigs.
    Yang C; Sheng T; Hou W; Zhang J; Cheng L; Wang H; Liu W; Wang S; Yu X; Zhang Y; Yu J; Gu Z
    Sci Adv; 2022 Dec; 8(48):eadd3197. PubMed ID: 36449622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-Responsive Microneedle Patches for Diabetes Treatment.
    Chen G; Yu J; Gu Z
    J Diabetes Sci Technol; 2019 Jan; 13(1):41-48. PubMed ID: 29848105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
    J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H
    Hu X; Yu J; Qian C; Lu Y; Kahkoska AR; Xie Z; Jing X; Buse JB; Gu Z
    ACS Nano; 2017 Jan; 11(1):613-620. PubMed ID: 28051306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microneedle-based insulin transdermal delivery system: current status and translation challenges.
    Zhao J; Xu G; Yao X; Zhou H; Lyu B; Pei S; Wen P
    Drug Deliv Transl Res; 2022 Oct; 12(10):2403-2427. PubMed ID: 34671948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats.
    Yue JT; Burdett E; Coy DH; Giacca A; Efendic S; Vranic M
    Diabetes; 2012 Jan; 61(1):197-207. PubMed ID: 22106159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.